DE69815126T2 - Pyrimidinderivate und verfahren zu deren herstellung - Google Patents

Pyrimidinderivate und verfahren zu deren herstellung Download PDF

Info

Publication number
DE69815126T2
DE69815126T2 DE69815126T DE69815126T DE69815126T2 DE 69815126 T2 DE69815126 T2 DE 69815126T2 DE 69815126 T DE69815126 T DE 69815126T DE 69815126 T DE69815126 T DE 69815126T DE 69815126 T2 DE69815126 T2 DE 69815126T2
Authority
DE
Germany
Prior art keywords
methyl
pyrimidine
fluorophenylamino
dimethyl
tetrahydroisoquinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69815126T
Other languages
German (de)
English (en)
Other versions
DE69815126D1 (de
Inventor
Wook Jong Kwachun-shi LEE
Yong Bong Suwon-shi LEE
Seop Chang Ansan-shi KIM
Kyu Seung Anyang-shi LEE
Seog Keun Anyang-shi SONG
Jin Song Euiwang-shi LEE
Jeon Woo SHIM
Soon Man Ansan-shi HWANG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yuhan Corp
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Publication of DE69815126D1 publication Critical patent/DE69815126D1/de
Application granted granted Critical
Publication of DE69815126T2 publication Critical patent/DE69815126T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69815126T 1997-03-27 1998-03-24 Pyrimidinderivate und verfahren zu deren herstellung Expired - Fee Related DE69815126T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR19970010862 1997-03-27
KR9710863 1997-03-27
KR9710862 1997-03-27
KR19970010863 1997-03-27
PCT/KR1998/000058 WO1998043968A1 (en) 1997-03-27 1998-03-24 Novel pyrimidine derivatives and processes for the preparation thereof

Publications (2)

Publication Number Publication Date
DE69815126D1 DE69815126D1 (de) 2003-07-03
DE69815126T2 true DE69815126T2 (de) 2004-04-08

Family

ID=26632616

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69815126T Expired - Fee Related DE69815126T2 (de) 1997-03-27 1998-03-24 Pyrimidinderivate und verfahren zu deren herstellung

Country Status (21)

Country Link
US (1) US6352993B1 (enExample)
EP (1) EP1015444B1 (enExample)
JP (1) JP3176379B2 (enExample)
KR (1) KR100278857B1 (enExample)
CN (1) CN1118464C (enExample)
AR (1) AR012181A1 (enExample)
AT (1) ATE241613T1 (enExample)
AU (1) AU720385B2 (enExample)
BR (1) BR9808070A (enExample)
CA (1) CA2284795C (enExample)
DE (1) DE69815126T2 (enExample)
DK (1) DK1015444T3 (enExample)
ES (1) ES2200324T3 (enExample)
HU (1) HUP0000851A3 (enExample)
IN (1) IN188411B (enExample)
PT (1) PT1015444E (enExample)
RU (1) RU2203894C2 (enExample)
TR (1) TR199902383T2 (enExample)
TW (1) TW542831B (enExample)
UY (1) UY24938A1 (enExample)
WO (1) WO1998043968A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100272471B1 (ko) 1998-11-17 2000-11-15 김선진 신규의 피리미딘 유도체 및 그의 제조방법
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
AR038368A1 (es) 2002-02-01 2005-01-12 Novartis Ag Compuestos n-pirimidin-2-il-aminas sustituidas como inhibidores de ige, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de un medicamento
JP4634144B2 (ja) 2002-08-01 2011-02-16 ニコックス エスエー ニトロソ化プロトンポンプ阻害剤、組成物および使用方法
WO2005009980A1 (en) * 2003-07-22 2005-02-03 Neurogen Corporation Substituted pyridin-2-ylamine analogues
JP4800216B2 (ja) * 2003-10-24 2011-10-26 エグゼリクシス， インコーポレイテッド ｐ７０Ｓ６キナーゼモジュレーターおよび使用方法
EP1974730A1 (en) 2003-11-03 2008-10-01 AstraZeneca AB Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux
KR101122376B1 (ko) * 2005-03-09 2012-03-26 주식회사유한양행 신규의 5,6-다이메틸피리미딘 유도체 및 그의 제조방법
US20090124645A1 (en) * 2005-10-14 2009-05-14 Neurosearch A/S Novel Pyrimidine-2,4-Diamine Derivatives and their Use as Modulators of Small-Conductance Calcium-Activated Potassium Channels
JP4946482B2 (ja) 2007-02-08 2012-06-06 船井電機株式会社 緩衝用梱包材及びｔｖ受像機の緩衝用梱包材
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
BRPI0917540A2 (pt) 2008-08-05 2015-11-17 Daiichi Sankyo Co Ltd composto, sal farmacologicamente aceitavél, composição farmacêutica, e, uso de um composto ou sal farmacologicamente aceitável
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
NZ610315A (en) 2010-11-15 2015-08-28 Univ Leuven Kath Antiviral condensed heterocyclic compounds
DK2678332T3 (en) * 2011-02-25 2016-08-15 Yuhan Corp Diaminopyrimidine derivatives and process for their preparation
CA2864825C (en) * 2012-02-17 2021-01-26 Abbvie Inc. Diaminopyrimidines useful as inhibitors of the human respiratory syncytial virus (rsv)
CN104334565A (zh) 2012-05-29 2015-02-04 莫门蒂夫性能材料有限责任公司 异氰酸基硅烷的制备
EA035349B1 (ru) 2012-11-21 2020-05-29 ПиТиСи ТЕРАПЬЮТИКС, ИНК. ЗАМЕЩЕННЫЕ ПИРИМИДИНОВЫЕ ОБРАТНЫЕ ИНГИБИТОРЫ Bmi-1
EP2970307B1 (en) 2013-03-13 2020-03-11 Genentech, Inc. Pyrazolo compounds and uses thereof
WO2015030847A1 (en) 2013-08-30 2015-03-05 Ptc Therapeutics, Inc. Substituted pyrimidine bmi-1 inhibitors
WO2015054317A1 (en) * 2013-10-07 2015-04-16 Kadmon Corporation, Llc Rho kinase inhibitors
WO2015076800A1 (en) 2013-11-21 2015-05-28 Ptc Therapeutics, Inc. Substituted pyridine and pyrazine bmi-1 inhibitors
JP2018502900A (ja) * 2014-10-22 2018-02-01 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム ジスコイジンドメイン受容体１を標的化する小分子阻害剤およびその使用
CN105669642B (zh) * 2014-11-19 2020-06-09 江苏天士力帝益药业有限公司 一种盐酸洛氟普啶的制备方法
LT3400217T (lt) * 2016-01-04 2022-06-27 Merck Serono S.A. Hidroksipropiltiazolidino karboksamido l-valinato darinys, jo druska ir jo kristalinė forma
EP3606915A1 (de) * 2017-04-05 2020-02-12 Bayer CropScience Aktiengesellschaft 2-amino-5-oxyalkyl-pyrimidinderivate und deren verwendung zur bekämpfung unerwünschten pflanzenwachstums
AU2019340402B2 (en) 2018-08-17 2025-04-03 Ptc Therapeutics, Inc. Method for treating pancreatic cancer
CN114685369B (zh) * 2022-05-17 2024-02-02 河南省科学院高新技术研究中心 一种利用离子液体制备1-甲基-1,2,3,4-四氢异喹啉的方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1182584A (en) 1966-03-31 1970-02-25 Ici Ltd Pyrimidine derivates and the use thereof as fungicides
US4000138A (en) 1966-03-31 1976-12-28 Imperial Chemical Industries Limited Organic compounds and compositions containing them
US3980781A (en) 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
US4044136A (en) 1972-09-09 1977-08-23 Pfizer Inc. Aminoquinazoline therapeutic agents
GB1383409A (en) 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
US3956495A (en) 1973-10-30 1976-05-11 Eli Lilly And Company 2,4-Diaminoquinazolines as antithrombotic agents
US4755218A (en) 1985-12-31 1988-07-05 Monsanto Company Haloacyl 1-substituted-1,2,3,4-tetrahydro-isoquinolines as herbicide antidotes
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
IL88507A (en) * 1987-12-03 1993-02-21 Smithkline Beckman Intercredit 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them
US4966622A (en) 1988-04-12 1990-10-30 Ciba-Geigy Corporation N-phenyl-N-pyrimidin-2-ylureas
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
DE3901448A1 (de) 1989-01-19 1990-07-26 Basf Ag Emulsionscopolymerisate
EP0388838B1 (de) 1989-03-22 1996-01-10 Ciba-Geigy Ag Schädlingsbekämpfungsmittel
CA2015981A1 (en) * 1989-05-10 1990-11-10 Thomas H. Brown Compounds
GB8910722D0 (en) 1989-05-10 1989-06-28 Smithkline Beckman Intercredit Compounds
GB9012592D0 (en) 1990-06-06 1990-07-25 Smithkline Beecham Intercredit Compounds
EP0556310B1 (en) 1990-11-06 1995-07-05 Pfizer Inc. Quinazolines derivatives for enhancing antitumor activity
ES2068714T3 (es) 1991-04-17 1995-04-16 Pfizer Derivados de pirimidina para aumentar la actividad antitumoral.
US5276186A (en) 1992-03-11 1994-01-04 Ciba-Geigy Corporation Process for the production of guanidine derivatives
KR0144833B1 (ko) 1992-12-28 1998-07-15 김태훈 신규의 퀴나졸린 유도체 및 그의 제조방법
CZ29996A3 (en) * 1993-08-12 1996-09-11 Astra Ab Amidine derivatives with activities of nitrogen oxide sythetase
DK0640599T3 (da) 1993-08-26 1998-09-28 Ono Pharmaceutical Co 4-Aminopyrimidin-derivater
WO1995010506A1 (en) 1993-10-12 1995-04-20 The Du Pont Merck Pharmaceutical Company 1n-alkyl-n-arylpyrimidinamines and derivatives thereof
CN1102144C (zh) * 1994-08-13 2003-02-26 株式会社柳韩洋行 新的嘧啶衍生物及其制备方法
WO1997042186A1 (en) * 1996-05-04 1997-11-13 Yuhan Corporation Process for preparation of pyrimidine derivatives

Also Published As

Publication number Publication date
HK1026418A1 (en) 2000-12-15
ATE241613T1 (de) 2003-06-15
CA2284795A1 (en) 1998-10-08
JP2000513014A (ja) 2000-10-03
CN1251586A (zh) 2000-04-26
AU720385B2 (en) 2000-06-01
PT1015444E (pt) 2003-10-31
ES2200324T3 (es) 2004-03-01
DE69815126D1 (de) 2003-07-03
CA2284795C (en) 2004-01-20
TW542831B (en) 2003-07-21
WO1998043968A1 (en) 1998-10-08
HUP0000851A1 (hu) 2001-04-28
RU2203894C2 (ru) 2003-05-10
BR9808070A (pt) 2000-03-08
AU6523998A (en) 1998-10-22
DK1015444T3 (da) 2003-08-18
CN1118464C (zh) 2003-08-20
US6352993B1 (en) 2002-03-05
UY24938A1 (es) 2001-01-31
KR19980080789A (ko) 1998-11-25
EP1015444B1 (en) 2003-05-28
EP1015444A1 (en) 2000-07-05
IN188411B (enExample) 2002-09-21
AR012181A1 (es) 2000-09-27
JP3176379B2 (ja) 2001-06-18
TR199902383T2 (xx) 2000-06-21
KR100278857B1 (ko) 2001-01-15
HUP0000851A3 (en) 2002-04-29

Similar Documents

Publication Publication Date Title
DE69815126T2 (de) Pyrimidinderivate und verfahren zu deren herstellung
DE69530989T2 (de) Neue pyrimidinderivate und verfahren zu ihrer herstellung
DE60217322T2 (de) Heterocyclische verbindung und antitumormittel, das diese als wirkstoff enthält
DE60110749T2 (de) Pyridinderivative als angiogenese- und/oder vegf-rezeptor-tyrosinkinase-inhibitoren
DE69423767T2 (de) 1,4-Benzodioxan-Derivate mit Affinität für D2 Rezeptoren und Nützlichkeit in der Behandlung von Psychosen
DE69619704T2 (de) Heteroacylcarbonsäureamiderivate
DE69330497T2 (de) Chinazolin-derivate
EP0129128A2 (de) 2-Pyrimidinyl-l-piperazin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
JPS626703B2 (enExample)
EP0013894B1 (de) Neue Arylether, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
JPH05148228A (ja) 新規１，４−二置換ピペリジン、その製法と治療用途
DE2415082A1 (de) Disubstituierte piperazine, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE69529619T4 (de) Pyrimidinylpyrazolderivative
DE69521037T2 (de) Chinazolinylamino derivate mit alfa-antagonist wirkung
DE69003465T2 (de) Chinazolinderivate.
EP1025100B1 (de) 3-substituierte tetrahydropyridopyrimidinon-derivate, ihre herstellung und verwendung
DE2332731A1 (de) Chinolin-carbonsaeure-(2)-verbindungen, verfahren zu ihrer herstellung sowie solche verbindungen enthaltende arzneimittelpraeparate
CA1211445A (en) Isoquinoline derivatives, a process for their preparation, pharmaceutical formulations based on these compounds and the use thereof
DE69927997T2 (de) Neuartige pyrimidin-derivate und verfahren zu ihrer herstellung
DE3782636T2 (de) Isoindolin-1-on-derivat und antiarrhythmisches mittel.
DE2614189A1 (de) Therapeutisch wirksame ureido- und semicarbazido-derivate des tiazols und verfahren zu ihrer herstellung
DE69805033T2 (de) Tetrazolderivate als LTD4 und H1 Antagonisten
EP2029580B1 (de) Neue indol-pyrrol-derivate zur behandlung proliferativer und inflammatorischer krankheiten
DE69013173T2 (de) Bisarylalkenderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzung, die sie enthalten.
DE69827614T2 (de) Chinoxalindionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee